CBUS
Cibus, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.59
+0.63%Margins
Gross margin
45.7%
EBITDA margin
-1356.0%
EBIT margin
-1240.9%
Net margin
-2258.9%
FCF margin
-1065.6%
-663.4%
Return on equity
-31.3%
Return on assets
-113.5%
Return on invested capital
0.01x
Asset turnover
-$46.1M
Cash from operations
$0.27
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026